METTL3 and hepatocellular carcinoma: We discovered a novel pathway in which O-GlcNAcylation regulates METTL3 and its targets in HCC, which aligns with the burgeoning consensus that PTMs are central to the modulation of RNA-modifying proteins, with profound implications for the epitranscriptome and disease progression.